Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Colloids Surf B Biointerfaces ; 231: 113573, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37783040

ABSTRACT

Polysaccharides have a variety of beneficial pharmacological impact on human health. Akebia trifoliata (Thunb.) Koidz. has promising development prospects as a food resource with medicinal value. The aim of this study was to investigate the structural characterization, antioxidant, and antibacterial properties of A. trifoliata (Thunb.) Koidz polysaccharides (ATKPs). ATKP-II was purified from ATKP by DEAE-cellulose column with NaCl solution as eluent. ATKP and ATKP-II structures were characterized by high performance gel permeation chromatography, gas chromatography, ultraviolet-visible, Fourier transform infrared spectroscopy, thermogravimetry analysis and scanning electron microscopy. ATKP and ATKP-II were primarily composed of rhamnose, arabinose, xylose, mannose, glucose, and galactose in a molar percent of 1.6: 22.1: 3.6: 6.3: 55.7: 10.7, and 0.5: 22.1: 3.7: 10.2: 42.1: 21.4, respectively. Their structure may contain ß-D-glucopyranose. The thermogravimetry analysis showed that ATKP and ATKP-II have good thermal stability at 230 °C and 200 °C, respectively. ATKP had the best antioxidant activities for 2, 2-diphenyl-1-picrylhydrazyl, hydroxyl, and superoxide free radical scavenging activities in vitro, and reducing ability than that of the purified polysaccharides. Moreover, ATKP was demonstrated an appreciable in vitro antibacterial activity, against Staphylococcus aureus, Bacillus subtilis, Salmonella, Penicillium italicum, Rhizopus and Aspergillus niger, but showed no activity against Escherichia coli and Saccharomycetes. These results demonstrated that ATKP displayed excellent antioxidant and antibacterial activities. This study provides a basis for the development and utilization in ATKP.


Subject(s)
Anti-Infective Agents , Antioxidants , Humans , Antioxidants/pharmacology , Antioxidants/chemistry , Spectroscopy, Fourier Transform Infrared , Polysaccharides/pharmacology , Polysaccharides/chemistry , Anti-Bacterial Agents/pharmacology , Anti-Infective Agents/pharmacology
2.
Foods ; 12(8)2023 Apr 13.
Article in English | MEDLINE | ID: mdl-37107427

ABSTRACT

This work aimed to investigate the preventive effect of Smilax china L. polysaccharide (SCP) on dextran sulfate sodium (DSS)-induced ulcerative colitis (UC) in mice. Smilax china L. polysaccharide was isolated by hot water extraction, ethanol precipitation, deproteinization, and purification using DEAE-cellulose column chromatography to yield three polysaccharides: SCP_C, SCP_A, and SCP_N. Acute colitis was induced by administering 3% (w/v) DSS in drinking water for 7 days. Sulfasalazine, SCP_C, SCP_A, and SCP_N were administered by gavage for 9 days. SCP_C, SCP_A, and SCP_N could significantly improve symptoms, as evidenced by the declining disease activity index (DAI), decreased spleen weight, increased length of the colon, and improved colonic histology. Moreover, SCP_C, SCP_A, and SCP_N increased serum glutathione and decreased the levels of pro-inflammatory cytokines, malondialdehyde, nitric oxide, and myeloperoxidase in colon tissues. Additionally, SCP_C, SCP_A, and SCP_N modulated gut microbiota via ascending the growth of Lachnospiraceae, Muribaculaceae, Blautia, and Mucispirillum and descending the abundance of Akkermansiaceae, Deferribacteraceae, and Oscillibacter in mice with UC. The results suggested that Smilax china L. polysaccharide ameliorates oxidative stress, balances inflammatory cytokines, and modulates gut microbiota, providing an effective therapeutic strategy for UC in mice.

3.
Plant Foods Hum Nutr ; 78(2): 299-306, 2023 Jun.
Article in English | MEDLINE | ID: mdl-36826691

ABSTRACT

Smilax china L. is an important herb used in traditional Chinese medicine. In this study, the mechanism of Smilax china L. polyphenols (SCP) on insulin resistance and anti-obesity in mice induced by a high-fat diet (HFD) was investigated. Fifty female mice were randomly divided into five groups: control, HFD and low, medium, and high doses of SCP for 70 d. SCP significantly decreased intraperitoneal adipose tissue index, body weight gain, liver lipids, and serum inflammatory factor levels. Blood glucose and insulin concentrations, as well as insulin resistance index in SCP, were significantly lower than those in HFD. In addition, SCP markedly up-regulated the gene expression of glucose transporter 4 (GLUT4), insulin receptor substrate 1 (IRS1), insulin receptor substrate 2 (IRS2), serine-threonine kinase (AKT), Acyl-CoA oxidase (ACO), and protein kinase A (PKA), and down-regulated the expression of mammalian target of rapamycin complex 1 (mTORC1), sterol-responsive element-binding protein-1c (SREBP1c), fatty acid synthase (FAS), 3-hydroxy-3-methyl glutaryl coenzyme A reductase (HMGCR), and forkhead box protein O1 (FOXO1). SCP significantly increased the protein expression of AKT, GLUT4, AMP-activated protein kinase (AMPK), phosphorylated-AMPK (p-AMPK), phosphorylated-AKT (p-AKT), and uncoupling protein 1 (UCP-1), and decreased the expression of SREBP1c, FAS, HMGCR, phosphorylation of IKBα (p-IKBα), and nuclear factor kappa B subunit p65 (P65) in the liver. Overall, SCP effectively reduced HFD-induced insulin resistance and obesity in mice, partly through NF-κB and IRS/AKT-AMPK signaling pathways to regulate inflammatory factors. Therefore, SCP may improve lifestyle diseases.


Subject(s)
Insulin Resistance , Smilax , Mice , Animals , NF-kappa B/metabolism , NF-kappa B/pharmacology , Diet, High-Fat/adverse effects , AMP-Activated Protein Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Proto-Oncogene Proteins c-akt/pharmacology , Smilax/metabolism , Polyphenols/pharmacology , Polyphenols/metabolism , Obesity/drug therapy , Obesity/etiology , Protein Serine-Threonine Kinases/metabolism , Protein Serine-Threonine Kinases/pharmacology , Liver , Signal Transduction/physiology , China , Mice, Inbred C57BL , Mammals/metabolism
4.
Am J Chin Med ; 50(2): 553-568, 2022.
Article in English | MEDLINE | ID: mdl-35114911

ABSTRACT

Smilax china L. is used not only as a kind of traditional Chinese herbal medicinal ingredients with various pharmacological properties, but also as food in certain parts of China. However, it is by far still unclear whether Smilax china L. polyphenols (SCP), as important bioactive constituents in Smilax china L., have effects on inflammatory bowel diseases (IBD). This study investigated the impact of SCP on the dextran sulfate sodium (DSS)-induced IBD and gut microbiota in mice. SCP treatments ameliorated typical symptoms of IBD as what was reflected through suppressing body weight loss, colonic shortening, intestinal barrier damage, and increasing intestinal disease activity index. SCP treatments simultaneously decreased the release of proinflammatory cytokines and oxidative stress, as well as promoted the release of anti-inflammatory factors. Furthermore, SCP ameliorated the ecological imbalance of gut microbiota and regulated the key bacteria associated with IBD (including Akkermansiaceae, Ruminococcaceae, Acidaminococcaceae, Muribaculaceae, and Anaeroplasmataceae). In general, SCP may improve DSS-induced IBD in mice by regulating inflammatory factors, inhibiting oxidative stress, reducing intestinal tissue damage, and regulating the ecological imbalance of intestinal microbiota. Thus, SCP might serve as a potential therapeutic agent against the inflammation-driven diseases.


Subject(s)
Colitis , Gastrointestinal Microbiome , Inflammatory Bowel Diseases , Smilax , Animals , Colitis/drug therapy , Colon , Cytokines , Dextran Sulfate/adverse effects , Disease Models, Animal , Inflammatory Bowel Diseases/chemically induced , Inflammatory Bowel Diseases/drug therapy , Mice , Mice, Inbred C57BL , Polyphenols/pharmacology
5.
Phytomedicine ; 95: 153728, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34561124

ABSTRACT

BACKGROUND: Smilax china L., a traditional Chinese herb, has been used to treat various inflammatory disorders, particularly pelvic inflammation. The anti-inflammatory activity of the plant extract has been reported in several in vivo experimental models. However, the underlying anti-inflammatory mechanisms and the role of gut microbiota in mice on Smilax china L. flavonoid (SCF) treatment are poorly understand. PURPOSE: To investigate the role of SCF in providing the anti-inflammatory response and the role of gut microbiota in high-fat/high-sucrose (HFHS)-induced obese mice for 12 weeks. STUDY DESIGN AND METHODS: C57BL/6J mice were randomly divided into seven groups, normal chow (NC), HFHS, Orlistat, SCE, and low-, medium-, high- doses of SCF for 12 weeks. The body weight, liver weight, serum concentrations of lipopolysaccharide (LPS), and inflammatory cytokines in mice were assessed. The gene and protein expression levels of inflammation-related markers were measured by qRT-PCR and Western blot. Finally, the composition of gut microbiota was detected by analyzing 16S rDNA gene sequences. RESULTS: SCF supplement reduced body weight gain, adipose tissue and liver indexes, attenuated serum levels of tumor necrosis factor (TNF)-α, interleukin (IL)-6, LPS, and increased IL-10, and adiponectin. SCF significantly reduced the mRNA expression levels of TNF-α, IL-6, and increased the expression of AMPK, PPAR-γ, and IL-10 in mice's liver and adipose tissues. In addition, the TLR4, p-IκBα, NF-κB, and p65 protein expression levels were reduced after the SCF supplement. Moreover, SCF treatment ameliorated HFHS-induced gut dysbiosis, as revealed by an increased intestinal barrier protective species (Akkermansia spp). The relative abundance of Streptococcaceae, Faecalibaculum, and endotoxin-producing Desulfovibrionaceae were significantly decreased on SCF supplements. CONCLUSION: The results showed that SCF effectively inhibits HFHS-induced inflammation by suppressing the LPS-producing bacteria and pro-inflammatory bacteria group. Furthermore, the abundance of gut barrier protective species Akkermansia spp was increased to alleviate inflammatory response, inhibiting the LPS-TLR4/NF-κB signaling pathway. Thus, SCF may be a promising prophylactic for diet-induced inflammatory diseases through the gut-liver axis in mice.


Subject(s)
Smilax , Animals , China , Flavonoids , Inflammation , Lipopolysaccharides , Liver , Mice , Mice, Inbred C57BL , NF-kappa B , Sucrose
6.
Food Funct ; 12(13): 5862-5875, 2021 Jul 05.
Article in English | MEDLINE | ID: mdl-34019043

ABSTRACT

The aim of this study was to investigate the effects of Smilax china L. flavonoid (SCF) on obesity and changes in gut microbiota high-fat/high-sucrose (HFHS)-fed mice. Male C57BL/6 mice fed either a normal-chow (NC) or a HFHS diet were treated with SCF for 12 weeks. The effect of SCF on the composition of gut microbiota was assessed by 16S rDNA sequencing. SCFA levels in the caecum were quantified by GC-MS. SCF supplementation alleviated the body weight gain, fat accumulation, serum lipid parameters, and hepatic steatosis and improved glucose homeostasis. SCF significantly increased plasma adiponectin level, adiponectin-receptor-gene (AdipoR1 and AdipoR2) expression in the liver, activated AMPKα, downregulated the expression of SREBP1-c, FAS, and ACCα, and upregulated the expression of PPARα, CPT-1α, and UCP-1. The anti-obesity effects of SCF might be through upregulation of adiponectin-receptor/AMPK signalling to improve lipid metabolism. SCF reversed HFHS-induced dysbiosis of gut microbiota and decreased SCFA production in the caecum, thus reducing energy absorption and leading to loss of body weight. Spearman's correlation analysis revealed significant correlations between obesity phenotypes, SCFA levels, and changes in gut microbiota. The results showed that SCF may be an effective dietary supplement that is useful for suppressing the development of obesity and associated disorders.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Flavonoids/pharmacology , Gastrointestinal Microbiome/drug effects , Obesity/prevention & control , Plant Extracts/pharmacology , Receptors, Adiponectin/metabolism , Smilax/chemistry , Up-Regulation/drug effects , Animals , Dietary Supplements , Disease Models, Animal , Dysbiosis , Fatty Liver/metabolism , Homeostasis/drug effects , Lipid Metabolism , Liver/metabolism , Male , Mice , Mice, Inbred C57BL , PPAR alpha , Weight Gain
7.
Article in English | MEDLINE | ID: mdl-32831873

ABSTRACT

OBJECTIVE: Gang-Qing-Ning (GQN) is a traditional Chinese medicine formula that has been used in the treatment of hepatocellular carcinoma (HCC) in the folk population for decades. However, scientific validation is still necessary to lend credibility to the traditional use of GQN against HCC. This study investigates the antitumor effect of GQN on H22 tumor-bearing mice and its possible mechanism. METHODS: Fifty H22 tumor-bearing mice were randomly assigned to five groups. Three groups were treated with high, medium, and low dosages of GQN (27.68, 13.84, and 6.92 g/kg, respectively); the positive control group was treated with cytoxan (CTX) (20 mg/kg) and the model group was treated with normal saline. After 10 days' treatment, the tumor inhibitory rates were calculated. Pathological changes in tumor tissue were observed, and the key proteins and genes of the mitochondrial apoptosis pathway were measured, as well as the mRNA expression levels of VEGF in tumor tissue. RESULTS: The tumor inhibitory rates of high, medium, and low dosages of GQN groups were 47.39%, 38.26%, and 22.17%, respectively. The high dosage of the GQN group significantly increased the protein and mRNA expression levels of Bax, Cyt-C, and cleaved Caspase 3 (or Caspase 3) (P < 0.01) but decreased the expression levels of Bcl-2, VEGF, and microvessel density (MVD) (P < 0.01). CONCLUSIONS: The high dosage of GQN can significantly inhibit the tumor growth in H22 tumor-bearing mice. It exerts the antitumor effect by enhancing proapoptotic factors and inhibiting the antiapoptotic factor of the mitochondrial apoptosis pathway and inhibiting tumor angiogenesis.

8.
Food Funct ; 10(11): 7489-7497, 2019 Nov 01.
Article in English | MEDLINE | ID: mdl-31670366

ABSTRACT

To investigate the mechanism of the combined effects of chlorogenic acid (CGA) and caffeine on lipid metabolism in high-fat diet-induced obese mice, eighty female ICR mice were randomly divided into eight groups and fed with a high-fat diet with/without CGA and/or caffeine for 14 weeks. The combination of CGA and caffeine effectively decreased body weight gain, intraperitoneal adipose tissue weight, serum LDL-c, FFA, TC, TG, leptin, IL-6 concentrations, and hepatic TG and TC levels and increased the serum adiponectin level. The CGA and caffeine combination also promoted the phosphorylation of AMPKα, inhibited the expressions of transcriptional regulators (SREBP-1c and LXRα), and decreased the expressions of FAS and HMGR. Besides, the expressions of ACO, ATGL and HSL were increased by the CGA and caffeine combinations. The results indicated that the combination of CGA and caffeine had anti-obesity effects and regulated lipid metabolism in high-fat diet-induced obese mice via the AMPKα-LXRα/SREBP-1c signaling pathway. Thus, chronic CGA and caffeine intakes may be potent for preventing obesity.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Caffeine/pharmacology , Chlorogenic Acid/pharmacology , Diet, High-Fat/adverse effects , Liver X Receptors/metabolism , Obesity/chemically induced , Adipose Tissue , Animals , Body Weight/drug effects , Caffeine/administration & dosage , Chlorogenic Acid/administration & dosage , Dose-Response Relationship, Drug , Drug Administration Schedule , Drug Synergism , Energy Intake , Female , Gene Expression Regulation/drug effects , Interleukin-6/blood , Leptin/blood , Lipids/blood , Liver/drug effects , Liver X Receptors/genetics , Mice , Mice, Inbred ICR , Sterol Regulatory Element Binding Protein 1/genetics , Sterol Regulatory Element Binding Protein 1/metabolism
9.
Appl Microbiol Biotechnol ; 103(21-22): 9013-9022, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31637496

ABSTRACT

This work aimed at investigating the chemical composition, antibacterial properties, and effect mechanism of Smilax china L. polyphenols (SCLP). SCLP was extracted and purified, and then, its eighteen polyphenolic compounds were identified by LC-MS/MS analysis. SCLP exhibited antibacterial activity against five bacteria (Salmonella typhimurium, Listeria monocytogenes, Staphylococcus aureus, Bacillus subtilis, and Escherichia coli) with minimum inhibitory concentration in a range of 195.31 to 781.25 µg/mL. Escherichia coli and Staphylococcus aureus showed a higher sensitivity to SCLP. Notably, when combined with antibiotics, the SCLP-thiamphenicol and SCLP-gatifloxacin combinations showed additional properties against Escherichia coli and Staphylococcus aureus, while SCLP-streptomycin and SCLP-penicillin combinations exhibited dramatically synergistic effects. In addition, the changes in permeability and integrity of the cell membrane and cell wall were observed by measuring UV absorption, extracellular AKP concentration, FTIR spectroscopy, and scanning electron microscopy. It is speculated that the mechanism of action of SCLP on bacteria may be described as destruction of bacterial cell wall and cell membrane. In conclusion, SCLP was a potential natural antimicrobial substance with strong antimicrobial activity, which may reduce the use of antibiotics or combat drug-resistant bacteria through synergistic combination with antibiotics.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Plant Extracts/pharmacology , Polyphenols/pharmacology , Smilax/metabolism , Anti-Bacterial Agents/metabolism , Cell Membrane/drug effects , Cell Wall/drug effects , Microbial Sensitivity Tests , Plant Extracts/metabolism , Polyphenols/metabolism
10.
Int J Biol Macromol ; 135: 127-132, 2019 Aug 15.
Article in English | MEDLINE | ID: mdl-31125649

ABSTRACT

Hydrocolloids have been widely used in the food industry as gelling agents, stabilizers and food thickeners to improve the viscosity, texture and stability of foods. Normally, individual polysaccharides or proteins do not form an excellent solid gel. Therefore, composite gels have received extensive attention. In this study, the effects of Smilax china L. starch (SCS) on the gel properties and interactions of CaSO4-induced soy protein isolate (SPI) gel was investigated. The gel properties of SCS-SPI gel system were analyzed by dynamic rheological, gel strength and water holding capacity. Synchronously, the interaction and microstructure of SCS-SPI gel system were evaluated by protein solubility and scanning electron microscope. Finally, the gel mechanism of the gel system was established. Viscosity, elasticity, gel strength and water holding capacity were obviously increased and microstructure become more compact of gel system and with the concentration increased of SCS. Furthermore, the result of protein solubility showed that hydrophobic, hydrogen bond and disulfide bond interaction play an important role on maintaining the gel system.


Subject(s)
Calcium Sulfate/chemistry , Gels/chemistry , Smilax/chemistry , Soybean Proteins/chemistry , Starch/chemistry , Chemical Phenomena , Hydrogen Bonding , Hydrophobic and Hydrophilic Interactions , Mechanical Phenomena , Rheology , Spectrum Analysis , Starch/ultrastructure
11.
Int J Biol Macromol ; 125: 445-452, 2019 Mar 15.
Article in English | MEDLINE | ID: mdl-30537499

ABSTRACT

The aim of this study is to investigate hypolipidemic and antioxidant effects of Pine needle polysaccharide (PNP) from Pinus massoniana in high-fat diet (HFD)-induced mice. PNP could significantly improve the serum lipid levels (total cholesterol, triacylglycerols, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol), enhance the antioxidant enzymes levels (total antioxidant capability, superoxide dismutase, glutathione peroxidase, catalase), and decrease malondialdehyde (MDA) content in HFD-induced mice. PNP exhibited distinct antioxidant ability on the superoxide anions, 1, 1-diphenyl-2-picrylhydrazyl (DPPH) and ferric ion reducing antioxidant power (FRAP) in vitro. The average molecular weight (Mw) of PNP was 6.17 × 105 Da, and mainly of fucose, arabinose, galactose, glucose, galacturonic acid. These results suggested that PNP might be used as functional foods and natural drugs in enhancing antioxidant ability and alleviating the hyperlipidemia.


Subject(s)
Antioxidants/pharmacology , Hypolipidemic Agents/pharmacology , Pinus/chemistry , Polysaccharides/pharmacology , Animals , Biphenyl Compounds/pharmacology , Catalase/metabolism , Cholesterol, HDL/metabolism , Cholesterol, LDL/metabolism , Diet, High-Fat/adverse effects , Female , Glutathione Peroxidase/metabolism , Hyperlipidemias/drug therapy , Hyperlipidemias/metabolism , Lipid Metabolism/drug effects , Lipid Peroxidation/drug effects , Liver/drug effects , Liver/metabolism , Malondialdehyde/metabolism , Mice , Mice, Inbred ICR , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Superoxide Dismutase/metabolism , Triglycerides/metabolism
12.
Exp Ther Med ; 13(2): 688-694, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28352352

ABSTRACT

Catechins and caffeine, which are green tea components, have a slimming effect; however, the combinational effect of fat metabolism in 3T3-L1 cells remains unclear. In the present study, 3T3-L1 cells were treated with catechins and caffeine in combination, and it was found that combination therapy with catechins and caffeine markedly reduced intracellular fat accumulation, mRNA expression levels of peroxisome proliferator-activated receptor-γ and CCAAT/enhancer-binding protein α in the early stage of cell differentiation were significantly reduced, and mRNA expression of fatty acid synthetase(FAS) andglycerol-3-phosphate dehydrogenase protein expression levels of FAS were downregulated. Noradrenaline-induced lipolysis was enhanced by caffeine, which markedly increased the protein expression of adipose triglyceride lipase and hormone sensitive lipase. These results indicated that combination therapy with catechins and caffeine synergistically inhibited lipid accumulation by regulating the gene and protein expression levels of lipid metabolism-related enzymes. Therefore, catechins and caffeine combination therapy has potential as a functional food that may be used to prevent obesity and lifestyle-associated diseases.

13.
Eur J Nutr ; 56(7): 2309-2318, 2017 Oct.
Article in English | MEDLINE | ID: mdl-27444711

ABSTRACT

PURPOSE: To investigate the mechanistic effects of combined exposure to caffeine and catechins on lipid metabolism in mice. METHODS: Seventy mice were randomly assigned to seven groups and fed diets containing varying doses of caffeine and catechins for 24 weeks. Body weight gain, intraperitoneal adipose tissue (IPAT) weight, serum biochemical parameters, and enzymatic activities, mRNA and protein expression levels of lipid metabolism-related enzymes in the liver and IPAT were analyzed. RESULTS: Following administration of caffeine and catechins, body weight gain, IPAT weight, serum and liver concentrations of total cholesterol and triglyceride were markedly reduced. Lipase activities, including that of AMP-activated protein kinase (AMPK), acyl-CoA oxidase, carnitine acyltransferase, adipose triglyceride lipase, and hormone-sensitive lipase, were significantly upregulated; however, fatty acid synthase (FAS) activity in the liver was suppressed. Combined exposure to caffeine and catechins significantly upregulated mRNA and protein expression levels of lipases while downregulating FAS mRNA expression and protein expression of peroxisome proliferator-activated receptor γ2. CONCLUSIONS: The combination of caffeine and catechins regulated the enzymatic activities, mRNA, and protein expression levels of lipid metabolism-related enzymes, resulting in suppression of body weight gain and IPAT weight in mice, potentially through activation of the AMPK signaling pathway. This study indicates that chronic intake of both caffeine and catechins can synergistically contribute to prevention of obesity and lifestyle-related diseases.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Caffeine/pharmacology , Catechin/pharmacology , Lipid Metabolism/drug effects , AMP-Activated Protein Kinases/genetics , Acyl-CoA Oxidase/genetics , Acyl-CoA Oxidase/metabolism , Animals , Biomarkers/blood , Carnitine Acyltransferases/genetics , Carnitine Acyltransferases/metabolism , Cholesterol/blood , Drug Synergism , Fatty Acid Synthases/blood , Feces/chemistry , Female , Lipase/genetics , Lipase/metabolism , Liver/drug effects , Liver/metabolism , Mice , Mice, Inbred ICR , Organ Size/drug effects , PPAR gamma/blood , Signal Transduction , Sterol Esterase/blood , Triglycerides/blood , Weight Gain
14.
PLoS One ; 10(3): e0122925, 2015.
Article in English | MEDLINE | ID: mdl-25822741

ABSTRACT

In order to investigate the mechanisms by which puerarin from kudzu root extract regulates lipid metabolism, fifty mice were randomly assigned to five groups: normal diet, high-fat diet (HFD), and HFD containing 0.2%, 0.4% or 0.8% puerarin for 12 weeks. Body weight, intraperitioneal adipose tissue (IPAT) weight, serum biochemical parameters, and hepatic and feces lipids were measured. Activity and mRNA and protein expressions of hepatic lipid metabolism-related enzymes were analyzed. Compared with HFD, 0.4% and 0.8% puerarin significantly decreased body and IPAT weight. There was a significant decrease in the serum and hepatic concentrations of total cholesterol, triglycerides and leptin in mice fed the 0.4% and 0.8% puerarin diets compared with HFD. Fatty acid synthase activity was suppressed in mice fed the 0.4% and 0.8% puerarin diets, while the activities of AMP-activated protein kinase (AMPK), carnitine acyltransferase (CAT) and hormone-sensitive lipase (HSL) were increased. mRNA expression of peroxisome proliferator-activated receptor γ 2 (PPARγ 2) was down-regulated in liver of mice fed the 0.8% diet compared with HFD, while mRNA expression of CAT and HSL was considerably up-regulated by 0.4% and 0.8% puerarin diets. The protein expression of PPARγ2 in liver was decreased and those of p-AMPK, HSL and p-HSL were increased in mice fed 0.4% and 0.8% puerarin diets. These results suggest that > 0.4% puerarin influenced the activity, mRNA and protein levels of hepatic lipid metabolism-related enzymes, decreasing serum and liver lipids, body weight gain and fat accumulation. Puerarin might be beneficial to prevent lifestyle-related diseases.


Subject(s)
Diet, High-Fat/adverse effects , Isoflavones/pharmacology , Lipid Metabolism/drug effects , Adipose Tissue/drug effects , Animals , Body Weight/drug effects , Eating/drug effects , Feces/chemistry , Female , Gene Expression Regulation, Enzymologic/drug effects , Liver/drug effects , Liver/enzymology , Liver/metabolism , Mice , Mice, Inbred ICR , Organ Size/drug effects , PPAR gamma/metabolism , Phosphorylation/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sterol Esterase/metabolism , fas Receptor/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...